Vincent J. Angotti is CEO at ACELRX PHARMACEUTICALS INC (ACRX). They have made 18 open-market trades across 2 companies since 2017, most recently 2026-04-02.
CIK 0001700225
18 open-market purchases totalling $797K since 2017, never a sale. Across 17 scored buys the stock is down 5.8% at ninety days, and 10.2 points behind the S&P over the same stretch.
18 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| TLPH | 790,767 | $858K |
| ACRX | 101,805 | $88K |
| Total | $946K |
Shares reported on the most recent Form 4, priced at the 2026-04-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 22% | 24% | 29% |
| Avg Move | -8.1% | -3.0% | -5.8% |
| Alpha | -6.9% | -4.2% | -10.2% |
| Scored | 18 | 17 | 17 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TLPH | BUY | 2026-03-13 | 2026-03-25 | $0.59 | $251K | -3.5% | -5.5% | +28.0% |
| TLPH | BUY | 2026-02-12 | 2026-02-20 | $0.81 | $85K | +5.8% | -7.0% | -5.3% |
| TLPH | BUY | 2025-04-02 | 2025-04-03 | $0.59 | $252K | -12.7% | -3.5% | -20.2% |
| TLPH | BUY | 2024-12-05 | 2024-12-06 | $0.64 | $3K | -9.0% | -6.9% | -23.3% |
| TLPH | BUY | 2024-11-27 | 2024-12-02 | $0.73 | $4K | -13.5% | -22.4% | -28.9% |
| TLPH | BUY | 2024-08-30 | 2024-09-03 | $1.05 | $8K | -10.9% | -21.8% | -25.7% |
| TLPH | BUY | 2024-06-12 | 2024-06-14 | $0.98 | $10K | -14.2% | -13.2% | -15.1% |
| ACRX | BUY | 2023-12-13 | 2023-12-14 | $0.73 | $7K | +0.5% | N/A | N/A |
| ACRX | BUY | 2023-09-11 | 2023-09-11 | $0.80 | $8K | -5.9% | -13.9% | -6.7% |
| ACRX | BUY | 2022-06-07 | 2022-06-08 | $0.22 | $10K | -11.8% | +38.4% | +24.3% |
| ACRX | BUY | 2020-06-15 | 2020-06-15 | $1.33 | $10K | -8.3% | -25.5% | -13.1% |
| ACRX | BUY | 2019-11-11 | 2019-11-12 | $1.79 | $15K | -5.7% | +31.3% | -4.0% |
| ACRX | BUY | 2019-06-05 | 2019-06-06 | $2.31 | $12K | -2.4% | -1.2% | -6.5% |
| ACRX | BUY | 2019-02-28 | 2019-03-04 | $2.81 | $9K | -22.1% | -11.6% | -37.0% |
| ACRX | BUY | 2018-12-14 | 2018-12-17 | $2.78 | $10K | -14.9% | -14.5% | +15.3% |
| ACRX | BUY | 2018-12-12 | 2018-12-12 | $2.99 | $30K | -28.8% | -12.7% | +3.3% |
| ACRX | BUY | 2018-08-07 | 2018-08-07 | $2.90 | $29K | +5.2% | +10.3% | +47.2% |
| ACRX | BUY | 2017-08-24 | 2017-08-24 | $3.00 | $45K | +6.6% | +27.9% | -30.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.